2025 promises to be a tumultuous year for the American healthcare and pharma sector. Increased scrutiny on pricing and the ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

2024 was eventful in the life sciences space – and key trends are expected to continue in the new year. Below, we outline key areas to watch in 2025. In recent years, several trends have heightened ...

What's on the horizon for the life sciences industry? Robin Johnson, PharmD, Gene Therapy Submissions Lead, inSeption Group What unique challenges do gene therapy submissions face compared to ...

Mariannette Miller-Meeks, a former ophthalmologist who represents southeast Iowa, has been a staunch advocate of PBM reform to lowering ... and end fuel supply disruptions once and for all ...

It’s the second major investigation into middlemen in the US medicines supply chain, coming after an ongoing FTC probe of pharmacy benefit management (PBM) companies, which started in 2022.

pharmacy benefit management companies, and government programs such as Medicare and Medicaid; coverage and reimbursement determinations by such payers and new policies and procedures adopted by ...

The individuals or companies within that complicated supply chain are what MCCPDC calls "the middlemen," namely pharmacy benefit managers (PBM ... from manufacturing to prescription delivery.

Given how interconnected the pharmacy supply chain is, every step to dismantle Big Three operations has a real impact. For employers or health plans that use a vertically integrated PBM to manage ...

The case could redefine state authority over PBM regulations, potentially lowering costs and allowing more flexible drug benefit plans. A ruling in favor of ERIC may set a legal precedent on state ...

It’s a similar argument to what Cigna Group, a Connecticut-based company that runs a large national health insurer plus a PBM called Express Script, is alleging with this new lawsuit ...